Tromboembolic recurrence parallel to the progression of breast cancer: Risk factors and central venous catheter thrombosis.

Losada B, Gutierrez D, Pantin

Abstract

Thromboembolic disease (VTE) is a very important cause of morbidity and mortality in cancer patients, with a recurrence rate between 10% -17% of patients treated with anti-Vitamin K drugs and 6-9% of low molecular weight heparin (LMWH) (1). This case reflects on the recurrence of VTE, the management of thrombosis associated with central venous catheter (CVC) and prothrombotic risk factors.